75 related articles for article (PubMed ID: 1515415)
1. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
Schmidt M; Schmidt AM; Dietl J; Kammerer U
Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
[TBL] [Abstract][Full Text] [Related]
3. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
[TBL] [Abstract][Full Text] [Related]
4. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
5. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
[TBL] [Abstract][Full Text] [Related]
8. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
Dubendorff JW; Lipsick JS
Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins.
Bhattacharya G; Lee L; Reddy ES; Rao VN
Oncogene; 1993 Dec; 8(12):3459-64. PubMed ID: 8247551
[TBL] [Abstract][Full Text] [Related]
11. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
Popova B; Bilan P; Xiao P; Faught M; Capone JP
Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
[TBL] [Abstract][Full Text] [Related]
13. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of transcriptional activation and oncogenic transformation by v-Myb.
Chen RH; Fields S; Lipsick JS
Oncogene; 1995 Nov; 11(9):1771-9. PubMed ID: 7478605
[TBL] [Abstract][Full Text] [Related]
15. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
16. Probing the Escherichia coli transcriptional activator MarA using alanine-scanning mutagenesis: residues important for DNA binding and activation.
Gillette WK; Martin RG; Rosner JL
J Mol Biol; 2000 Jun; 299(5):1245-55. PubMed ID: 10873449
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
18. Functional dissection of the transcription factor Elk-1.
Janknecht R; Zinck R; Ernst WH; Nordheim A
Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters.
Oum JH; Han J; Myung H; Hleb M; Sharma S; Park J
Mol Cells; 2002 Feb; 13(1):77-84. PubMed ID: 11911478
[TBL] [Abstract][Full Text] [Related]
20. Delta elk-1, a variant of elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity.
Rao VN; Reddy ES
Cancer Res; 1993 Jan; 53(2):215-20. PubMed ID: 8417810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
